Citation Impact
Citing Papers
Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte
2010 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
5 Treatment and prognostic factors in acute myeloid leukaemia
1996
Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease.
1989
Etoposide: four decades of development of a topoisomerase II inhibitor
1998 Standout
A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group Study.
1992
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
PARMA international protocol: Pilot study on 50 patients and preliminary analysis of the ongoing randomized study (62 patients)
1991
Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation
2005
Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial
1998
Amifostine
2001
A Randomized Trial of Surgery in the Treatment of Single Metastases to the Brain
1990 Standout
Salivary hypofunction: An update on aetiology, diagnosis and therapeutics
2014
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Amifostine in clinical oncology: current use and future applications
2002
Bone marrow autotransplantation
1989
Dose Intensification of Etoposide in the BEAM ABMT Protocol for Malignant Lymphoma
1995
Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemia
2002
Anthrazykline in der Krebstherapie
1997 Standout
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
Animal models of autoimmunity and their relevance to human diseases
2000 StandoutNobel
Localized invasive pulmonary aspergillosis in patients with neutropenia. Effectiveness of surgical resection
1993
Evaluating treatment strategies in chronic lymphocytic leukemia
2001
Biological roles of glycans
2016 Standout
Autologous bone marrow transplantation in children
1988
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
Aggressive surgical management in localized pulmonary mycotic and nonmycotic infections for neutropenic patients with acute leukemia: Report of eighteen cases
1998
Graft-versus-host disease
2009 Standout
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
The pathobiology of mucositis
2004 Standout
Aspergillosis Case-Fatality Rate: Systematic Review of the Literature
2001 Standout
Hematopoietic Stem-Cell Transplantation
2006 Standout
A review of autologous hematopoietic cell transplantation
2000 Nobel
Idarubicin
1991
The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group
2004
Membrane Plasmapheresis in the United States: A Review Over the Last 20 Years
2001
Autologous Bone Marrow Transplantation
1989
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Cancer of the Ovary
2004 Standout
Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignancies
1988
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Bone Marrow Transplantation
1993
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Clinacanthus nutansExtracts Are Antioxidant with Antiproliferative Effect on Cultured Human Cancer Cell Lines
2013 Standout
Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway
2017 StandoutNobel
Bone marrow and peripheral blood stem cell transplantation for malignancy.
1998
Chemotherapy of brain metastases: Current status
1984
Anthracycline analogs The past, present, and future
1986
Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma
1994
Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia
1992
Fludarabine in the treatment of chronic lymphocytic leukemia: a review
2009
How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study
2003 Standout
Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia
2005
High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
1987
The Absolute Number of Peripheral Blood CD34+ Cells Predicts a Timing for Apheresis and Progenitor Cell Yield in Patients with Hematologic Malignancies and Solid Tumors
2003 StandoutNobel
Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors
2000
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
The pharmaceutics and delivery of therapeutic polypeptides and proteins
1993
The Risk of Determining Risk with Multivariable Models
1993 Standout
Aspergillus fumigatusand Aspergillosis
1999 Standout
Bone Marrow Transplant
1990 Standout
Specificity of Effector T Lymphocytes in Autologous Graft-Versus-Host Disease: Role of the Major Histocompatibility Complex Class II Invariant Chain Peptide
1997
The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial
1998 Standout
Acute toxicity and first clinical results of intensive postinduction therapy using a modified busulfan and cyclophosphamide regimen with autologous bone marrow rescue in first remission of acute myeloid leukemia [see comments]
1989
Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia
1991
Anthraquinones As Pharmacological Tools and Drugs
2016 Standout
Parma international protocol: pilot study of DHAP followed by involved- field radiotherapy and BEAC with autologous bone marrow transplantation
1991
Works of S Nati being referenced
Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphoma.
2001
Cascade filtration with reverse rinse of the secondary filter
1987
Cyclosporine-induced graft-versus-host disease after autologous bone marrow transplantation in hematological malignancies
1991
Idarubicin in combination with intermediate‐dose cytarabine in the treatment of refractory or relapsed acute leukemias*
1989
A New Combination of Idarubicin, Etoposide and Cytarabine in Untreated Acute Non-Lymphoblastic Leukemia
1990
First line Fludarabine treatment of symptomatic chronic lymphoproliferative diseases: clinical results and molecular analysis of minimal residual disease
1998
Autologous Unpurged Bone Marrow Transplantation for Acute Non Lymphoblastic Leukemia in First Remission
1991
Idarubicin in combination with etoposide and cytarabine in adult untreated acute non lymphoblastic leukemia
1987
Idarubicin in combination with etoposide and cytarabine in adult acute non-lymphoblastic leukaemia (ANLL).
1989
Autologous bone marrow transplantation as adjuvant treatment for high-risk Hodgkin's disease in first complete remission after MOPP/ABVD protocol.
1991
Massive chemotherapy with non-frozen autologous bone marrow transplantation in 13 cases of refractory Hodgkin's disease
1985
Amifostine (WR-2721), a cytoprotective agent during high-dose cyclophosphamide treatment of non-Hodgkin's lymphomas: a phase II study
2000
Autologous unpurged bone marrow transplantation for acute non-lymphoblastic leukaemia in first complete remission.
1988
4-Demethoxydaunorubicin (Idarubicin) in refractory or relapsed acute leukemias. A pilot study
1985
High Dose BCNU Followed by Autologous Bone Marrow Infusion in Glioblastoma Multiforme
1981
High-dose chemotherapy and non-frozen autologous bone marrow transplantation in relapsed advanced lymphomas or those resistant to conventional chemotherapy
1984